|CompTox Dashboard (EPA)|
|Chemical and physical data|
|Molar mass||373.46 g/mol g·mol−1|
|3D model (JSmol)|
Volinanserin (INN) (developmental code name MDL-100,907) is a highly selective 5-HT2A receptor antagonist that is frequently used in scientific research to investigate the function of the 5-HT2A receptor. It was also tested in clinical trials as a potential antipsychotic, antidepressant, and treatment for insomnia but was never marketed.
|This drug article relating to the nervous system is a stub. You can help Wikipedia by expanding it.|